MRI markers of glymphatic dysfunction in tuberculous meningitis: associations with CSF proteins and cognitive

Yilin Wang1,2, Wei He2, Yongbo Li3

  • 1Department of Radiology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.

Abstract

Insights

The diffusion tensor imaging along the perivascular spaces (DTI-ALPS) index shows promise for predicting cognitive impairment in tuberculous meningitis (TBM) patients, correlating with cognitive function and prognosis.

Area of Science:

  • Neuroimaging
  • Neurology
  • Infectious Diseases

Background:

  • Tuberculous meningitis (TBM) often leads to mild cognitive impairment (MCI).
  • Glymphatic system dysfunction, assessed via imaging, is linked to cognitive decline but its role in TBM is unclear.
  • Cerebrospinal fluid (CSF) protein changes in TBM patients are not fully understood in relation to cognitive function.

Purpose of the Study:

  • To investigate the relationship between glymphatic function markers, cognitive performance, and CSF proteins in TBM patients using fMRI.
  • To evaluate the diagnostic and prognostic potential of glymphatic imaging markers in TBM-associated cognitive impairment.

Main Methods:

  • 123 participants (61 healthy controls, 30 TBM-nonMCI, 32 TBM-MCI) underwent MRI and cognitive tests.
  • Evaluated perivascular space (PVS) load, diffusion-tensor imaging along the perivascular spaces (DTI-ALPS) index, and choroid plexus volume (CPV).
  • Analyzed CSF proteomics and used correlation and mediation analyses to link glymphatic metrics, CSF proteins, and cognition.

Main Results:

  • TBM patients had altered hippocampal PVS and choroid plexus volume (CPV) compared to controls; TBM-MCI patients showed lower ALPS and higher basal ganglia PVS.
  • ALPS indices and hippocampal PVS correlated positively with cognitive measures, while CPV showed inverse correlations.
  • The ALPS index predicted cognitive prognosis (AUC=0.857) and distinguished TBM-MCI from controls (AUC=0.719), with CSF proteins not mediating these relationships.

Conclusions:

  • Altered perivascular clearance markers (ALPS, CPV) are associated with cognitive decline in TBM.
  • The ALPS index is a potential biomarker for predicting cognitive dysfunction and prognosis in TBM.
  • Further research into glymphatic system mechanisms in TBM is warranted.